FINALLY, ANNULAR CLOSURE IS BEING USED IN THE U.S., AGAIN (Orthopedics This Week)
Barrachaid website
More than 500 patients have been treated with the newly FDA approved Barricaid annular closure device—in Europe.
Manufactured by Woburn, Massachusetts-based Intrinsic Therapeutics, Barricaid was tested in a European multicenter, randomized controlled trial involving 554 patients. The study outcomes led investigators to conclude that using Barricaid reduced the rate of recurrent symptomatic herniation by approximately 50% when compared to patients treated with discectomy alone.
The inaugural U.S...
